Clinical Trial Update: Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC) [Phase 2]

View source ↗

Summary

Phase 2 trial update shows ongoing immunotherapy combined with yttrium-90 SIRT therapy for intrahepatic cholangiocarcinoma; the study is currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• Immunotherapy (unspecified)
• Y-90 SIRT therapy (yttrium-90 selective internal radiation therapy)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING